Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis-Reference-Cited by-同舟云学术

Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis

Published:2022-01-30 Issue:6 Volume:18 Page:642-649
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clncl Oncology

Author:

Chazan Grace¹,Anton Angelyn²,Wong Shirley³,Shapiro Julia⁴,Weickhardt Andrew⁵,Azad Arun¹⁴,Kwan Edmond M⁴⁶,Spain Lavinia⁴⁷,Gunjur Ashray⁵,Torres Javier⁸,Parente Phillip⁴⁷,Parnis Francis⁹¹⁰,Goh Jeffrey¹¹¹²,Gibbs Peter²³,Tran Ben¹²

Affiliation:

1. Peter MacCallum Cancer Centre Melbourne Australia

2. Walter and Eliza Hall Institute Melbourne Australia

3. Western Health Melbourne Australia

4. Department of Medicine School of Clinical Sciences Monash University Melbourne Australia

5. Olivia Newton‐John Cancer Wellness and Research Centre Melbourne Australia

6. Department of Medical Oncology Monash Health Melbourne Australia

7. Eastern Health Melbourne Australia

8. Goulburn Valley Health Shepparton Australia

9. Adelaide Cancer Centre Adelaide Australia

10. Department of Medicine University of Adelaide Adelaide Australia

11. Royal Brisbane and Women's Hospital Brisbane Australia